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Abstract
Although 18F-fluoro-deoxy-glucose (FDG) positron emission tomography (PET) has been widely validated and extensively used in 
the latest years in clinical practice, interpretation of PET/CT images can be affected by several pitfalls. We here present a case of 
intense lung uptake in a patient without a corresponding finding on CT images, probably due to a microembolism produced during 
the injection process and located in small vascular structures of the lung parenchyma.
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Introduction
18F-fluoro-deoxy-glucose (FDG) positron emission tomography 
(PET) has been widely validated and extensively used in the latest 
years in clinical practice for a large variety of purposes. In particu-
lar, the indications for PET/computed tomography (CT) examina-
tions make it one of the most promising imaging techniques in 
oncology for staging and restaging purposes and for treatment 
response evaluation [1]. 
Anyway, often interpretation of PET/CT images can be affected 
by several pitfalls or variants, which can have dramatic impact on 
PET accuracy [2].
We here present a case of intense lung uptake in a patient 
without a corresponding finding on CT images.
Case report
A 34 year-old man came to our observation for staging pur-
poses after being diagnosed with a subcutaneous lesion in right 
lumbar region, pathologically confirmed as sarcoma.
The patient underwent a PET/CT scan using a hybrid Biograph 
mCT TOF PET/CT scanner (Siemens Medical Solution AG) and 
was scanned approximately 1 hour after the intravenous adminis-
tration of 224 MBq 18F-FDG from the base of the skull through the 
pelvis with a 90-s time of acquisition per bed position. 
There was the evidence of an intense uptake involving the 
subcutaneous lesion in right lumbar region (Figure 1); moreover, 
another intense uptake (SUVmax > 100) involving the lower lobe 
of the left lung was detected, without any corresponding lesion 
on CT images used for attenuation correction (Figure 2, arrows).
The unusually increased FDG uptake in the left lung in the 
absence of any focal lesion in the parenchyma suggested the 
possibility of an artefact.
Since the PET finding in the lung did not have a corresponding 
lesion on CT images and since this could considerably change the 
therapeutic approach, the patient repeated PET acquisition one 
hour later in breath hold and the intense uptake was still present.
We therefore performed a high resolution chest CT without 
contrast medium, revealing no lesions as well in the left lung. 
The patient underwent surgical excision of the subcutane-
ous mass and is currently on follow-up. A restaging 18F-FDG 
PET/CT was performed one month later and showed no pathologi-
cal uptakes in the lungs.
Discussion
Pitfalls and common variants in 18F-FDG uptake must be kept 
on mind when interpreting PET/CT images, since the accuracy 
of the technique can be seriously affected by this drawback [2]. 
Anyway, the possibility of using hybrid PET/CT systems allows to 
accurately study any suspected pathological lesion in order to 
determine whether it is pathological or not.
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In our case, we found high incidental FDG accumulation in the 
lung parenchyma without any corresponding lesion on CT images, 
thus suggesting a possible artefact.
Some cases have been reported in literature about this rela-
tively rare pitfall.
Figure 1. Transaxial, sagittal and coronal PET/CT fused images evidencing an intense subcutaneous uptake in the right lumbar region
Figure 2. Transaxial images on corresponding slices on PET, CT and fused PET/CT images. There is an evidence of intense uptake in the lower 
lobe of the left lung on PET images, without corresponding lesions on CT (arrows)
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Hany et al. [3] described 3 cases of abnormal FDG uptake 
in the lungs, suggesting a possible microembolism which could 
explain the high FDG concentration.
Other authors described similar cases [4–7], also suggesting 
the opportunity not to miss a misregistered pulmonary nodule that 
appears in a different level on the CT images [5].
This possible drawback was excluded in our case by perform-
ing a late acquisition in breath hold, which has been demonstrated 
to limit possible artefacts due to the respiratory motion which 
causes an overestimation of tumor volume, degrades the contrast, 
and interferes with SUV evaluation resulting in reduced PET/CT 
accuracy [8].
A well accepted explanation of FDG uptake in the lungs is that 
microembolisms produced during the injection process and located 
in small vascular structures of the lung parenchyma could be the 
cause of this artefact. 
A suggested physiological mechanism is that after an alteration 
of the vascular endothelium, as it happens during paravenous injec-
tion, high flow of materials, location of the needle tip, or aspiration 
of blood, tiny blood clots may be produced and enter the small 
pulmonary vessels thus causing distal microembolism [3, 6].
This microembolism causes platelet activation; once activated, 
platelets adhere to the subendothelium and subsequently ag-
gregate, releasing the contents of the a-cytoplasmic granules by 
exocytosis [4]. 
All the steps of this activation process cause an intense con-
sumption of extracellular glucose, which can be transported into 
the activated platelet by the glucose transporter GLUT-3, which 
has been demonstrated to be the major agent responsible for 
glucose uptake in such conditions [9, 10]. In particular, GLUT-3, 
when platelets are activated by thrombin, induces an increase in 
glucose transport for a factor of 3 to 5 [10]. 
Since GLUT-3 receptors are mainly stored in platelets and 
translocate to the cell surface after activation by thrombin [4, 9], 
this could explain the high 18F-FDG uptake observed in the left 
lung on PET images.
Another possible mechanism is the neutrophil activation 
as a primary mediator of lung vascular injury after pulmonary 
microembolism [6], causing a translocation of GLUT-1 from the 
cell interior to the cell surface and a dose-dependent increase in 
glucose uptake [9, 11, 12].
Our case report supports what previously observed by other 
authors and suggest the opportunity of considering the possibility 
of an artefact when an abnormal FDG uptake is detected. In fact, 
although technology has greatly improved in latest years regarding 
hardware and software, artefacts are still present and always will be.
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